Opinion - The House Must See the Whole Mueller Report

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks
263
Quote:
Opinion - The House Must See the Whole Mueller Report

Someday, Trump will not be in office. Congress needs a full accounting of his misdeeds to ensure they don’t happen again.

By Jerrold L. Nadler
Mr. Nadler is the chairman of the House Judiciary Committee.
April 1, 2019

Last Sunday, Attorney General William Barr sent us a letter summarizing what he says are the “principal conclusions” of the special counsel, Robert Mueller. The next day, together with five other committee chairmen, I wrote back to the attorney general, demanding that he provide us with the full Mueller report — not a summary, but the full report and all of the relevant evidence — by April 2.

For nearly two years, the country has waited to read the report. Over those many months, President Trump has raged against the institutions that make our democracy possible — among them, the free press, the courts and his own Department of Justice. When the special counsel indicted members of the president’s inner circle, his attacks got louder.

Before the formal investigation began, Mr. Trump fired his F.B.I. director. He later fired his attorney general. He reportedly attempted to fire the special counsel himself. Despite this profoundly unacceptable behavior, the special counsel persevered and wrote his report.

We — the members of the Judiciary Committee, the House of Representatives and the entire American public — are still waiting to see that report. We will not wait much longer. We have an obligation to read the full report, and the Department of Justice has an obligation to provide it, in its entirely, without delay. If the department is unwilling to produce the full report voluntarily, then we will do everything in our power to secure it for ourselves.

The entire reason for appointing the special counsel was to protect the investigation from political influence. By offering us his version of events in lieu of the report, the attorney general, a recent political appointee, undermines the work and the integrity of his department. He also denies the public the transparency it deserves. We require the full report — the special counsel’s words, not the attorney general’s summary or a redacted version.

We require the report, first, because Congress, not the attorney general, has a duty under the Constitution to determine whether wrongdoing has occurred. The special counsel declined to make a “traditional prosecutorial judgment” on the question of obstruction, but it is not the attorney general’s job to step in and substitute his judgment for the special counsel’s.

That responsibility falls to Congress — and specifically to the House Judiciary Committee — as it has in every similar investigation in modern history. The attorney general’s recent proposal to redact the special counsel’s report before we receive it is unprecedented. We require the evidence, not whatever remains after the report has been filtered by the president’s political appointee.

On its face, the attorney general’s letter raises more questions than it answers. He tells us, for instance, that he declined to charge the president with obstruction in part because there was no underlying crime to obstruct.

Did he discuss that conclusion with Deputy Attorney General Rod Rosenstein — who, while a federal prosecutor, routinely charged individuals with obstruction without charging the underlying crime? Did the attorney general forget that the special counsel indicted 37 other people, including the president’s campaign manager, deputy campaign manager and former national security adviser, for various crimes, including conspiracy against the United States? Did he lose track of his own prosecutors, who effectively named the president as an unindicted co-conspirator in the Southern District of New York?

Second, we require the report because Congress has a role that is fundamentally different from that of the Department of Justice. The special counsel’s mandate was narrow: investigate allegedly criminal conduct stemming from links between the Trump campaign and the Russian government. Our job is to hold the president accountable any time he undermines the rule of law, and is not limited to his involvement with the Russian government during the campaign.

Whether or not the president could have been charged with a crime, even the attorney general acknowledges the existence of evidence that has so far been hidden from view. We have every reason to suspect that the unedited obstruction section of the Mueller report resembles the report that Congress received from the Watergate grand jury in 1974. That evidence showed that President Richard Nixon had attempted to obstruct justice. It did not recommend that the president should be prosecuted. It did not say the president should be impeached. It simply stated the evidence so that Congress could do its job.

Finally, we require the report because one day, one way or another, the country will move on from President Trump. We must make it harder for future presidents to behave this way. We need a full accounting of the president’s actions to do that work.

When the full scope of the president’s misconduct has been revealed, when his lies are debunked and his abuses have been laid bare, I believe that members of Congress on both sides of the aisle will draft legislation to curb the worst of his offenses. Put another way: If President Trump’s behavior wasn’t criminal, then perhaps it should have been.

Related
More on the Mueller report.

Opinion | The Editorial Board
No Collusion, No ‘Exoneration’
March 24, 2019
https://www.nytimes.com/2019/03/24/opinion/mu...pe=Article

Opinion | Neal K. Katyal
The Many Problems With the Barr Letter
March 24, 2019
https://www.nytimes.com/2019/03/24/opinion/ba...pe=Article

Opinion | David Leonhardt
William Barr, Media Handler
March 26, 2019
https://www.nytimes.com/2019/03/26/opinion/wi...pe=Article

https://www.nytimes.com/2019/04/01/opinion/mu...trump.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Mobilize for Action Against Organon & Co. (OGN) Claims

Updated Category News Views 248

Mobilizing for Justice: Organon & Co. Class Action Lawsuit Overview Recent developments have drawn serious attention to Organon & Co. (NYSE: OGN), as investors set their sights on a class action lawsuit aimed at seeking justice for significant financial losses incurred. The legal proceedings are a reaction to purported misleading statements made by the company’s...

Continue Reading
Humana's 2024 Third Quarter Results Show Financial Resilience

Updated Category News Views 107

Humana Reports Third Quarter Financial Results for 2024 Humana Inc. (NYSE: HUM) has recently disclosed its consolidated financial results for the third quarter of 2024, highlighting a comprehensive overview of its performance compared to the previous year. Despite prevailing challenges within the healthcare sector, the organization showcased solid financial resilience and...

Continue Reading
CobbleStone Joins Civic Marketplace for Easy Gov't Procurement

Updated Category News Views 21

CobbleStone Software Goes Digital with Civic Marketplace Sometimes in this tech-driven world, it feels like the old-school bureaucratic processes just can't keep up. Enter CobbleStone Software, a name that's ringing bells in the halls of government offices with a neat little trick up its sleeve: integrating its contract management platform into the Civic Marketplace. It's...

Continue Reading
Shineco Inc Faces Stock Challenges Amid Recovery Efforts

Updated Category News Views 186

Shineco Inc Stock Experiences Significant Decline Shineco Inc (SISI) has reached a concerning milestone as its stock plummets to a 52-week low at $1.92. With a market capitalization of only $3.64 million, this dip reveals ongoing issues within the company's financial landscape. Analysts have pegged its financial health score as 'WEAK', bringing to light several risk...

Continue Reading
Epsilon Energy Reflects on Strategic Acquisitions in Oil and Gas

Updated Category News Views 254

Epsilon Energy’s Latest Strategic Acquisition Epsilon Energy Ltd. (NASDAQ: EPSN), a prominent player in North American onshore natural gas and oil production, has completed significant acquisitions, marking an important chapter in the company’s expansion strategy. Through the recent purchase of Peak Exploration and Production LLC and Peak BLM Lease LLC, referred to as...

Continue Reading